The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kupriyanova A.G.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Molochkova Yu.V.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Setdikova G.R.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Molochkov A.V.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Sukhova T.E.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Molochkov V.A.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

IgM-dependent bullous pemphigoid

Authors:

Kupriyanova A.G., Molochkova Yu.V., Setdikova G.R., Molochkov A.V., Sukhova T.E., Molochkov V.A.

More about the authors

Read: 678 times


To cite this article:

Kupriyanova AG, Molochkova YuV, Setdikova GR, Molochkov AV, Sukhova TE, Molochkov VA. IgM-dependent bullous pemphigoid. Russian Journal of Clinical Dermatology and Venereology. 2025;24(2):191‑197. (In Russ.)
https://doi.org/10.17116/klinderma202524021191

Recommended articles:
Effi­cacy of dupi­lumab application in bullous pemphigoid proceeding in presence of bronchial asthma. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):204-209

References:

  1. Khalaf Kridin and Ralf J. Ludwig The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations Review Front Med (Lausanne). 2018 Aug 20:5:220.  https://doi.org/10.3389/fmed.2018.00220
  2. Borradori L, Van Beek N, Feliciani C, et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV) J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1689-1704. https://doi.org/10.1111/jdv.18220
  3. Schmidt E, Zellikens D. Pemphigoid diseases. Lancet. 2013;381:320-332. 
  4. Yoko Hirano, Hiroaki Iwata, Masumi Tsujuwaki, Shoko Mai, Yosuke Mai, Keisuke Imafuku, Kentaro Izumi, Hiroshi Koga, Hideyuki Ujiie. Super-resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid. J Dermatol. 2022 Mar;49(3):374-378. Epub 2021 Nov 30.  https://doi.org/10.1111/1346-8138.16260
  5. Katharina Boch, Christoph M Hammers, Stephanie Goletz, Mayumi Kamaguchi, Ralf J Ludwig, Stefan W Schneider, Detlef Zillikens, Eva Hadaschik, Enno Schmidt. Immunoglobulin M pemphigoid. J Am Acad Dermatol. 2021 Dec;85(6):1486-1492. Epub 2021 Jan 13.  https://doi.org/10.1016/j.jaad.2021.01.017
  6. van Beek N, Kruger S, Fuhrmann T, et al. Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology. J Am Acad Dermatol. 2020;83:1315-1322.
  7. Mareike Witte, Detlef Zillikens and Enno Schmidt. Diagnosis of Autoimmune Blistering Diseases. Front. Med. 2018;5:296.  https://doi.org/10.3389/fmed.2018.00296
  8. Feliciani C, Joly P, Jonkman MF, Zambruno G, Zillikens D, Ioannides D, et al. Management of Bullous Pemphigoid: The European Dermatology Forum Consensus in Collaboration With the European Academy of Dermatology and Venereology. Br J Dermatol. 2015;172:867-877.  https://doi.org/10.1111/bjd.13717
  9. Franziska Schauer, David Rafei-Shamsabadi, Shoko Mai, et al. Hemidesmosomal Reactivity and Treatment Recommendations in Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid — A Retrospective, Monocentric Study. Front Immunol. 13:953546. https://doi.org/10.3389/fimmu.2022.953546
  10. Beletskaya LV, Kupriyanova AG, et al Heart allograft rejection of the humoral type is a continuing “rheum-like” process. J Heart Lung Transplant. 2006 Aug;25(8):998-1000.
  11. Kupriyanova AG, Beletskaya LV, Zaydenov VA, et al. The experience of immunohistochemical investigation of endomiocardial biopsies for the diagnosis of the humoral rejection in the patients whith heart allograft. Bulletin of Transplantology and Artificial Organs. 2009;11(3):30-37. (In Russ.).
  12. Romeijn TR, Jonkman MF, Knoppers C, Pas HH, Diercks GFH. Complement in Bullous Pemphigoid: Results from a Large Observational Study. Br J Dermatol. 2017;176:517-519. [CrossRef].
  13. Velthuis PJ, de Jong MC, Kruis MH. Is there a linear IgM dermatosis? Significance of linear IgM junctional staining in cutaneous immunopathology. Acta Derm Venereol. 1988;68(1):8-14. 
  14. Roos A, Essers M, van Gijlswijk-Janssen D, Bovin NV, Daha MR. Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity. Xenotransplantation. 2001 Feb;8(1):3-14.  https://doi.org/10.1046/j.0908-665x.2000.00087.x
  15. Sanjay Khandelwal, Joann Ravi, Lubica Rauova, et al. Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway. Blood. 2018 Dec 06;132(23):2431-2440. https://doi.org/10.1182/blood-2018-03-834598
  16. Rosalie Baardman, Barbara Horváth, PhD, Maria C Bolling, Hendri H Pas and Gilles FH. Diercks Immunoglobulin M bullous pemphigoid: An enigma JAAD Case Rep. 2020 Jun;6(6):518-520. Published online 2020 Apr 21. PMCID: PMC7256243; PMID: 32490114. https://doi.org/10.1016/j.jdcr.2020.04.008
  17. Tazudeen N, Au S, Pewitt J, Tu E, Aronson IK. IgM ocular cicatricial pemphigoid: a unique insight into the immune system. Dermatol Online J. 2015 Oct 16;21(10):13030/qt40z314gz. PMID: 26632795.
  18. Beletskaya LV, Kupriyanova AG, Baranova FS. C4d-complement component as one of the humoral rejection marker. J Heart and Lung Transplantation. 2005 Aug;24(8):1125-1126.
  19. Murata K, Baldwin WM III. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody mediated rejection. Transplant Rev (Orlando). 2009 July;23(3):139-150. 
  20. Vodegel RM, Jonkman MF, Pas HH, et al. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol. 2004;151:112-118. 
  • Bernier A, Rumyantseva T, Reques L, Volkova N, Kyburz Y, Maximov O, Derrienic E, Guschin A, Bouscaillou J, Luhmann N, Pataut D. HIV and other sexually transmitted infections among female sex workers in Moscow (Russia): prevalence and associated risk factors. Sex Transm Infect. 2020 Dec;96(8):601-607.  https://doi.org/10.1136/sextrans-2019-054299
  • Shipitsyna E, Khusnutdinova T, Budilovskaya O, et al. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia. Eur J Clin Microbiol Infect Dis. 2020;39(7):1221-1230. https://doi.org/10.1007/s10096-020-03831-w
  • Email Confirmation

    An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

    Email Confirmation

    We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.